One microsatellite polymorphism in the HO-1 gene promoter has been evaluated in several disease entities, including pulmonary disease [28], [29], cardiovascular disease [30], [31], [32], obstetrics [33], and neurological disease [34]. This evidence concerns the gene HMOX1 and lung disorder.